Jointown Pharmaceutical Group Co Ltd operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jointown Pharmaceutical Group Co Ltd with three other
companies in this sector in China:
China National Accord Medicines Corporation Limited
sales of 41.24 billion Chinese Renmimbi [US$6.40 billion]
of which 75%
Huadong Medicine Company Limited
(25.38 billion Chinese Renmimbi [US$3.94 billion]
of which 79%
was Commerce), and
China Medicine Health Industry Co Ltd
(25.74 billion Chinese Renmimbi [US$3.99 billion]
of which 67%
was Pharmaceutical Business).
During the year ended December of 2016, sales at
Jointown Pharmaceutical Group Co Ltd were 61.55 billion Chinese Renmimbi (US$9.55 billion).
increase of 24.2%
versus 2015, when the company's sales were 49.58 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Jointown Pharmaceutical Group Co Ltd
(and since 2011, sales have increased a total of 148%).
Sales of Retail saw an increase
that was more than double the company's growth rate: sales were up
63.6% in 2016, from
984.48 million Chinese Renmimbi to 1.61 billion Chinese Renmimbi.
Jointown Pharmaceutical Group Co Ltd also saw significant increases in sales in
Other (up 63.6% to 138.55 million Chinese Renmimbi)
Not all segments of Jointown Pharmaceutical Group Co Ltd experienced an increase in sales in 2016:
sales of Industry fell 16.4% to 215.29 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).